Mannitol-sucrose mixtures - Versatile formulations for protein lyophilization

被引:127
作者
Johnson, RE [1 ]
Kirchhoff, CF [1 ]
Gaud, HT [1 ]
机构
[1] Pharmacia Corp, Res & Dev, Skokie, IL 60077 USA
关键词
lyophilization; mannitol; sucrose; protein;
D O I
10.1002/jps.10094
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Mixtures of sucrose (a lyoprotectant) and mannitol (a bulking agent) have been investigated as excipients for the lyophilization of proteins. Four proteins under development have been successfully lyophilized in a formulation of 4% mannitol and 1% sucrose using a lyophilization cycle that produces a cake of crystalline mannitol and amorphous sucrose. The crystalline mannitol allows primary drying to be performed with a product temperature of -10degreesC even though the sucrose is amorphous and, by itself, would have required primary drying below -35degreesC to avoid cake collapse. Formation of an unstable mannitol hydrate is avoided by conducting secondary drying at 40degreesC or higher. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:914 / 922
页数:9
相关论文
共 18 条
[1]  
Burger A, 2000, J PHARM SCI-US, V89, P457, DOI 10.1002/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO
[2]  
2-G
[3]  
Cannon AJ, 2000, PDA J PHARM SCI TECH, V54, P13
[4]  
Cavatur R K, 1998, Pharm Dev Technol, V3, P579, DOI 10.3109/10837459809028642
[5]   STUDY OF DIFFERENT CRYSTALLINE FORMS OF MANNITOL - COMPARATIVE BEHAVIOR UNDER COMPRESSION [J].
DEBORD, B ;
LEFEBVRE, C ;
GUYOTHERMANN, AM ;
HUBERT, J ;
BOUCHE, R ;
GUYOT, JC .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1987, 13 (9-11) :1533-1546
[6]  
FRANKS F, 1990, CRYO-LETT, V11, P93
[7]  
Haikala R, 1997, PDA J PHARM SCI TECH, V51, P96
[8]   LYOPHILIZED FORMULATIONS OF RECOMBINANT TUMOR-NECROSIS-FACTOR [J].
HORA, MS ;
RANA, RK ;
SMITH, FW .
PHARMACEUTICAL RESEARCH, 1992, 9 (01) :33-36
[9]  
IZUTSU K, 1994, CHEM PHARM BULL, V42, P5
[10]   The physical state of mannitol after freeze-drying: Effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute [J].
Kim, AI ;
Akers, MJ ;
Nail, SL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (08) :931-935